Don has extensive experience in the life science industry, with successful experience with start-ups, major multinationals and management/strategy consulting firms. Throughout his career, his focus has been on identifying, assessing, acquiring/licensing and commercializing technology platforms that address significant unmet medical needs.
Previously, Don spent 24 years in management consulting Newbridge Consulting Group and Redding Consultants. Clients served include GSK, Medtronic, Kimberly Clark, US Surgical, and WHO. He began his career in life sciences at G.D. Searle & Co / Pfizer and Eli Lilly, where he was promoted through senior management positions.
Don has had significant roles in a number of successful global new product and line extension launches within pharmaceuticals, medical devices, and consumer healthcare/ nutraceuticals. These include Nutrasweet/Equal, MenAfriVac, Verapamil, Metamucil, Cu-7, Demulen, and Endo Stitch.
Don has served as a Commercial Advisor to the NIH, the World Bank and the World Health Organization. He currently serves on the Grant Review Committee for the Florida State Research Foundation and is a Director and Principal of The Co-Investment Partnership, LLC. which manages a seed-stage fund.